LEMAITRE VASCULAR, INC.

LMAT ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $1.6M
Depreciation & Amortization $1.4M
Depreciation
Amortization
Stock-Based Compensation $985.0K
Net Cash from Operating Activities $5.4M
Investing Activities
Capital Expenditures $577.0K
Business Acquisitions $759.0K
Net Cash from Investing Activities $2.2M
Financing Activities
Dividends Paid
Stock Repurchases $686.0K
Net Cash from Financing Activities $-376.0K
Net Change in Cash $7.3M
Free Cash Flow $4.9M
← Newer Page 3 of 3 Older →